A New NF-κB Inhibitor, MEDS-23, Reduces the Severity of Adverse Post-Ischemic Stroke Outcomes in Rats

Aim: Nuclear factor kappa B (NF-κB) is known to play an important role in the inflammatory process which takes place after ischemic stroke. The major objective of the present study was to examine the effects of MEDS-23, a potent inhibitor of NF-κB, on clinical outcomes and brain inflammatory markers...

Descripción completa

Detalles Bibliográficos
Autores principales: Rubin, Elina, Pippione, Agnese C., Boyko, Matthew, Einaudi, Giacomo, Sainas, Stefano, Collino, Massimo, Cifani, Carlo, Lolli, Marco L., Abu-Freha, Naim, Kaplanski, Jacob, Boschi, Donatella, Azab, Abed N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773493/
https://www.ncbi.nlm.nih.gov/pubmed/35053779
http://dx.doi.org/10.3390/brainsci12010035

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8773493/
https://www.ncbi.nlm.nih.gov/pubmed/35053779
http://dx.doi.org/10.3390/brainsci12010035

Ejemplares similares